ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
Reviewing the Rheumatoid Arthritis Treatment Landscape
Reviewing the Rheumatoid Arthritis Treatment Landscape
Understanding Pain Management in Children with Neurological Disorders
Understanding Pain Management in Children with Neurological Disorders
Innovations in Adherence: Long-Acting Agents for Infectious Diseases
Innovations in Adherence: Long-Acting Agents for Infectious Diseases
Promising results for self-expanding TAVR device in trial with mostly women
Promising results for self-expanding TAVR device in trial with mostly women
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Climate Change and Neurological Infections: The Effects Over Time
Climate Change and Neurological Infections: The Effects Over Time
Preventive PCI versus optimal medical therapy only for vulnerable plaques
Preventive PCI versus optimal medical therapy only for vulnerable plaques
Uncovering a Potential Biomarker for Myasthenia Gravis
Uncovering a Potential Biomarker for Myasthenia Gravis
Maternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
Maternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
Managing Internal Medicine Issues in Hospitalized Neurological Patients
Managing Internal Medicine Issues in Hospitalized Neurological Patients
Recognizing and Addressing Medical Gaslighting in Healthcare
Recognizing and Addressing Medical Gaslighting in Healthcare
Self-assessment on statin eligibility without prescription using a web app
Self-assessment on statin eligibility without prescription using a web app
Promising results for APOC3 ASO in familial chylomicronemia syndrome
Promising results for APOC3 ASO in familial chylomicronemia syndrome
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
